Hemispherx Biopharma (HEB)
1.8 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
- - - - -
HEB Detailed Quote
I liked the original name better lol. Still think this drug has great potential, but I’m disappointed there wasn’t any news from the Japan trials.
‘AIM’ is the new ticker.
No, the company changed its name and ticker. There’s a new board.
Buying all i can it may be a long haul there is probably a reason they taking shares instead of all their pay. Hopefully a buy out.
This drug could be huge in the me/cfs community, I really thought it would’ve received approval here in the states.
They need cash so they can hit their finish and fill due in October...and they need to poly-line recertified for that to happen. They are still planning to send product to Argentina (filed the paperwork) - so regardless of what they in their PRs...someone in management is still pursuing ME/CFS where they have approvals to build on.
Their voting now to raise the share count from 2018
Acusphere has twice as many shares moves ez this should rocket eiyh the right hedge or buy out merger
Ok their not adding shares could be a 2008 run cant tell whats bottom they bought in at 2.30? Legally
they do this to themselves
So they rs to 2.2m shares then dilute 70m shares https://seekingalpha.com/article/893871-tracking-recent-buy-calls-and-investments-by-the-maxim-group
I hope the can run a pump and dump and clay can do a video.
Ampligen is picking up steam
News: $HEB Hemispherx Biopharma Announces First Patient Treated in Phase 2 Ovarian Cancer Clinical Trial Evaluating Ampligen in Combination with Pembrolizumab and Cisplatin
OCALA, Fla., June 12, 2019 (GLOBE NEWSWIRE) -- (NYSE American: HEB) — Hemispherx Biopharma Inc. announced today that the first patient has been treated in the Phase 2 recurrent ovarian cancer program at the University of Pittsburgh Medical Center (UPMC) (See: https://clinicaltrials...
In case you are interested https://marketwirenews.com/news-releases/hemispherx-biopharma-announces-first-patient-treated-in-phase-2-ovarian-cancer-clinical-trial-evaluating-ampligen-in-combination-with-pembrolizumab-and-cisplatin-8346632.html
News: $HEB Hemispherx Biopharma Stockholders Approve Reverse Stock Split
OCALA, Fla., May 31, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases, today announced that its stockholders voted in...
Read the whole news https://marketwirenews.com/news-releases/hemispherx-biopharma-stockholders-approve-reverse-stock-split-8277778.html
They have investors after the rs or people to buy in. They have been selling out with each pump. Hope they have a ringer in the fda. Or 10 years later the same pumps as 2008
News: $HEB Hemispherx Links Stanford's ME/CFS Diagnostic to a Potential Path Forward for Ampligen Commercialization
OCALA, Fla., May 06, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma Inc., (NYSE American: HEB), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases — and whose product portfolio includes Amp...
In case you are interested https://marketwirenews.com/news-releases/hemispherx-links-stanford-s-me-cfs-diagnostic-to-a-potential-path-forward-for-ampligen-commercialization-8123236.html
WOW that's insane!!!! Thanks for sharing the actual numbers ;)
So the warrant exercise price has been reduced to .15?! These guys are sucker punching retail! They would be delisted already if they traded on the the NAZ. JMO
The following table illustrates the dilution:
Offering price per share $0.15
Net tangible book value per share as of December 31, 2018 $(0.0875 )
Increase in net tangible book value per share after this offering $(0.0041)
Pro forma net tangible book value per share after this offering $(0.916 )
Dilution per share to the investor in this offering $0.0584
As I said several times, no value here, but pure CRAP.
sinking fast here
Where are all these shares coming from? It seems we have gone through all the OS after yesterday and this morning. We don't know what the float is but reading the OS at the OTC. So again were are all these shares coming from? The flippers have to be out now. Are the Shares being shorted by
the MM's? Again too new to trading to know what is going on with HEB..I would appreciate any input ;)
Where is the news? Thanks
$heb..huge news out today..shorts scrambling premarket...